Veröffentlicht am in "Business", Sprache — English. 5 Seiten.
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Mehr anzeigen
